I recently developed a few mAbs that are able to neutralize SARS2. By ELISA and WB, I found that they all bind to SARS2 RBD. I wanted to map their RBD epitopes so I ordered pre-coated plates with each well containing a 15-mer peptide spanning SARS2 RBD. There was a 5aa overlap between each peptide/well. I wanted to make sure I was doing everything right so I just tried it with one of my mAbs and found that the mAb bound to the first 8 wells, i.e spanning the first 44 amino acids of SARS2 RBD. I was expecting just one single well to light up, not 8 of them. Anyone can tell me what I could do to improve this? Or how this can be explained? I don't want to test the rest of the mAbs until I know what's going on to not waste the plates/peptides.